APOBEC3A驱动人类胃上皮的脱氨酶突变
Yohan An1, Ji-Hyun Lee2, Joonoh Lim3
1Korea Advanced Institute of Science and Technology (KAIST).
Genome research
|August 26, 2025
概括
催化型多类 (APOBEC) 酶与癌症突变有关. 这项研究显示,APOBEC3A在正常胃细胞中具有强烈的突变性,而APOBEC3B的突变性活性很小.
科学领域:
- 遗传学
- 分子生物学
- 癌症研究
背景情况:
- APOBEC酶与癌症基因组中的DNA突变有关.
- 单个APOBEC酶在正常人细胞中的特定突变作用尚未完全理解.
研究的目的:
- 在正常人胃器官系中比较APOBEC3A和APOBEC3B的突变性活性.
- 描述由APOBEC3A引起的突变场景.
主要方法:
- 全基因组测序人类正常的胃器官线.
- 对APOBEC3A和APOBEC3B的表达是可诱导的.
- 分析突变光谱,包括内部突变和集群突变.
主要成果:
- 转录上调APOBEC3A导致基因组突变在几个细胞周期内显著增加.
- APOBEC3B的上调导致了脱氨酶活性和DNA损伤,但胃上皮的突变增加很小.
- 即使在TP53失活的情况下,APOBEC3B相关的突变发生率也很低.
- APOBEC3A诱导了一种独特的突变谱,包括1bp删除和集群突变.
结论:
- 在正常人胃细胞中,APOBEC3A是一种强大的变异原体.
- APOBEC3B在胃上皮表现出有限的突变性.
- 了解APOBEC酶的突变性对于癌症发病和进化研究至关重要.
相关概念视频
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
In-vitro Mutagenesis
14.2K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.2K
What is Monogastric Digestion?
72.5K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
72.5K


